Leading today’s list is Ariel Emanuel, CEO of TKO Group Holdings $TKO, making waves with an eye-popping $77 million purchase.
When a CEO drops this kind of cash on their own stock, it screams confidence in the company’s future.
Kenneth Courtis, independent director of Alpha Metallurgical Resources $AMR, followed suit with a hefty $2.4 million buy. Insider moves like this often hint at good things to come, or at least an upward move in the stock.
Here’s The Hot Corner, with data from December 18, 2024:
ConocoPhillips $COP saw action too, as director R.A. Walker scooped up 10,400 shares in the latest Form 4 filing.
But that’s not all. The president and CEO of 3D Systems Corporation $DDD, Jeffrey Graves, doubled down with a bold move, snapping up 60,000 shares of his own company’s stock.
Baker Bros Advisors, renowned for their biotech expertise, increased their stake in Bicycle Therapeutics $BCYC from 19.76% to 22.90%, as disclosed in a 13D filing.
This signals strong confidence in the company's prospects, likely tied to its innovative "Bicycles" platform for developing novel therapies.
Given the Bakers' track record, their investment is a notable endorsement of Bicycle Therapeutics' potential.
In essence, when the Bakers buy, biotech investors pay attention.
Here’s The Hot Corner, with data from December 17, 2024:
Two notable insider purchases were disclosed via Form 4 filings in the energy sector:
PBF Energy Inc $PBF: Control Empresarial de Capitales SA reported a purchase, adding $5,357,162 to its current position.
Diamondback Energy $FANG: Director Steven West also disclosed buying shares for $975,960.
OPKO Health $OPK CEO Phillip Frost just put his money where his mouth is, snapping up 500,000 of OPK shares at $1.56 each.
Remember, executives sell for many reasons. But they only buy because they believe in their company and think it will have a higher stock price in the future.
Frost is clearly placing his chips on OPKO’s future.
Here’s The Hot Corner, with data from December 11, 2024:
Director David B. Smith, Jr. bought 635 shares of Illinois Tool Works $ITW, equivalent to $174,752.
ARK Investment Management is making waves with its latest move.
In a recent 13G filing, Cathie Wood and her team increased their stake in CRISPR Therapeutics AG $CRSP from 8.78% to 10.69%.
This move makes CRSP the fifth largest holding in ARK’s portfolio, highlighting their strong belief in the company and its groundbreaking work in gene editing.
Every time ARK Investment Management makes a move, it’s worth paying attention – and their latest activity is no exception.
Here’s The Hot Corner, with data from December 10, 2024:
Adding to the activity, GIC Private Ltd., Singapore's sovereign wealth fund, disclosed an initial 5.66% stake in Paymentus Holdings $PAY in a schedule 13G.
Last but not least, we witnessed insider activity in PBF Energy $PBF, Matador Resources Company $MTDR and Biglari Holdings Inc $BH.
Thilo Schroeder, director of Revolution Medicines $RVMD and managing member of Nextech Invest, made waves with a $60 million insider buy, acquiring 1.3 million shares.
Nextech, known for investing in cutting-edge life sciences companies, often backs transformative players in oncology.
Schroeder's move underscores his confidence in RVMD’s potential.
Here’s The Hot Corner, with data from December 9, 2024:
Kevin Tang, President of Tang Capital Management, filed a Form 4 revealing a $10,822,000 purchase in Aurinia Pharmaceuticals Inc $AUPH.
Last but not least, the CEOs of MSCI Inc $MSCI and Biglari Holdings Inc $BH both filed Form 4s, revealing purchases of their own stock.
Control Empresarial de Capitales SA is at it again!
The Mexican investment giant just dropped $9.25 million on more shares of PBF Energy Inc $PBF, pushing its ownership stake to a hefty 24.20%.
What’s noteworthy is that Control Empresarial continues to build its position in PBF despite the stock’s current trend being far from ideal.
This move highlights Control Empresarial’s strong conviction and a clear long-term focus.
Here’s The Hot Corner, with data from December 6, 2024:
In another Form 4, director Jeffrey C. Campbell, who is also the CFO of American Express, bought 6,000 shares of Marathon Petroleum Corportion $MPC for $149.60, a total purchase of $897,642.
The most significant transaction on today's list comes in a Form 4 filing featuring both the CEO and the CFO of Dorchester Minerals $DMLP.
Together, they purchased almost $1 million worth of their own company's stock.
When two top executives with the deepest insight into the company’s operations and financial health simultaneously make significant insider purchases, it indicates the stock is undervalued or that upcoming developments could positively impact the performance.
Here’s The Hot Corner, with data from December 5, 2024:
In another Form 4, director Dirk J. Debbink bought 1,000 shares, equivalent to $157,188 in Cincinnati Financial Corporation $CINF.
The most notable insider transaction today is a Form 4 filing by John H. Stone, President and CEO of Allegion plc $ALLE.
Stone purchased 7,500 ALLE shares, totaling $1 million.
Meanwhile, Sardar Biglari, CEO and founder of Biglari Holdings Inc $BH, reported an additional purchase of BH shares valued at $1,499,970.
While CEO buys aren’t necessarily signals for immediate action, such transactions often reflect strong confidence in a company’s future and can serve as a supportive factor for long-term bullish trends.
Here’s The Hot Corner, with data from December 4, 2024:
HHLR Advisors Ltd has increased its stake in BeiGene $BGNE from 5.30% to 9.00%, as disclosed in a recent 13G filing. BGNE is now Hillhouse’s largest holding.
For the second day in a row, M. Grier Eliasek, President and COO of Prospect Capital Corporation $PSEC, disclosed a significant insider buy – 210,000 shares, totaling $1,010,058.
Here’s The Hot Corner, with data from December 3, 2024:
These c-suite leaders typically have the most insight into the business's health and prospects, making their investments worth paying extra attention to.